Clinical characteristics of tuberculosis patients in a tertiary hospital by KOBASHI Yoshihiro et al.
41Kawasaki Medical Journal 46：41－48，2020　doi：10.11482/KMJ-E202046041
Corresponding author
Yoshihiro Kobashi
Department of Respiratory Medicine, Kawasaki 
Medical School, 577 Matsushima, Kurashiki, 701-0192, 
Japan
Phone : 81 86 462 1111
Fax : 81 86 464 1041
E-mail: yoshihiro@med.kawasaki-m.ac.jp
Clinical characteristics of tuberculosis patients in a tertiary hospital
Yoshihiro KOBASHI,  Masaaki ABE,  Daisuke YOSHIOKA,  Shigeki KATO, Toru OGA
Department of Respiratory Medicine, Kawasaki Medical School
ABSTRACT   We retrospectively assessed the clinical characteristics of tuberculosis patients 
in a tertiary hospital. The subjects consisted of 80 patients who Mycobacterium tuberculosis  
was isolated from clinical specimens and who received a definite diagnosis of tuberculosis 
in our tertiary hospital without isolated bedrooms between January 2010 and June 2018. The 
average age of the 80 patients was 68.3 years old, consisting of 43 males and 37 females (6 
non-Japanese). Sixty-eight patients had underlying diseases, and malignant diseases were most 
frequently recognized. Seven patients were diagnosed as outpatients and the remaining patients 
were diagnosed after admission. The final diagnose consisted of 56 patients with pulmonary 
tuberculosis and 35 patients with extrapulmonary tuberculosis (tuberculous lymphadenitis, 
tuberculous pleurisy, miliary tuberculosis, etc.). Concerning the results of interferon-γ release 
assays (IGRAs), while the positive response rate of QFT was 75%, that of T-SPOT was 81%. 
The clinical specimens used to diagnose tuberculosis were as follows: expectorated sputum, 
26 patients; bronchoscopic specimens, 32; biopsy tissue, 17; and others, 5. The interval from 
the first consultation to diagnosis was three months at the maximum and within one month in 
most patients. Regarding radiological findings, pulmonary lesions including miliary tuberculosis 
showed various atypical findings: 39 of 66 patients with bilateral lesions; 50 with no cavity 
lesion; and 13 with the extent of the lesion exceeding the unilateral lung field. 
   Tuberculosis patients in our tertiary hospital had many underlying diseases such as malignant 
or autoimmune diseases and were receiving immunosuppressive treatment. Therefore, because 
IGRAs do not always show a positive response and radiological findings also do not show 
typical findings, it is important to investigate acid-fast bacilli for various clinical specimens and 
actively perform diagnostic methods including bronchoscopy in order to prevent nosocomial 
infection.  doi：10.11482/KMJ-E202046041　(Accepted on April 9, 2020)
Key words： Tuberculosis,  Clinical Characteristics,  Tertiary Hospital
〈Regular Article〉
to 12.3 per 100,000 people in 2018 in Japan１）. 
However, nine million people newly develop TB 
every year worldwide and one-third of the global 
INTRODUCTION
   The incidence of tuberculosis (TB) declined 
gradually from 31.0 per 100,000 people in 2000 
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investigated the outcome at transfer hospitals in 
cases of hospital transfer as far as possible. 
   Concerning microbiological examinations, 
clinical specimens such as expectorated sputum, 
bronchoscopy, tissue, and pleural fluid were directly 
examined by Ziehl-Neelsen staining. The specimens 
used for culture were digested and decontaminated 
by the sodium hydroxide method. The samples were 
used to inoculate slants of 1% Ogawa egg medium, 
and bacteria were identified and differentiated 
based on growth characteristics and conventional 
biochemical tests. Drug sensitivity tests for isolated 
M. tuberculosis were performed using Bit-spectrum-
SR (Kyokuto Pharmaceutical Industrial Co., Ltd.). 
The levels of resistance to antituberculous drugs 
such as streptomycin (SM), isoniazid (INH), 
rifampicin (RFP), ethambutol (EB), kanamycin 
(KM), enviomycin (EVM), ethionamid (TH), 
cycloserine (CS), paraaminosalicylate (PAS), and 
levofloxacin (LVFX) were assessed. 
   Regarding the radiological findings on admission, 
the portion, extension of lesion, and radiological 
findings according to the Japanese Society for 
Tuberculosis (JST) were evaluated based on both 
chest radiographs and computed tomography (CT). 
Finally, we reviewed the radiological findings such 
as cavities, calcifications, pleural effusions, and 
lower lung field dominance described by Segerra et 
al.７）.
   The study protocol was approved by the Ethical 
Committee of Kawasaki Medical School (Approval 
No. 2554).
RESULTS
   We present the background of patients with TB 
encountered in our hospital in Table 1. During 
the observation period, 80 patients were enrolled 
in this study. They consisted of 43 males (54%) 
and 37 females (46%) with a mean age of 68.3 
years old. Most patients (85%) had underlying 
diseases (respiratory diseases: 26% and non-
population is thought to be infected with TB２）. 
According to World Health Organization (WHO) 
reports, while TB appeared in many patients with 
HIV-coinfection in South-East Asia and Africa, it 
was characterized by appearing most frequently 
among elderly patients in some Western Pacific 
countries２）.  Concerning risk factors of TB 
reactivity, malnutrition and immunodeficiency 
play important roles based on previous reports３，４）. 
However, there have been few recent reports on the 
clinical characteristics of tuberculosis patients in 
tertiary hospitals in Japan. Because Mycobacterium 
tuberculosis shows an air-bone infection type, it 
is important to investigate the clinical findings of 
TB patients and be aware of the known clinical 
characteristics to prevent hospital infection in 
tertiary hospitals. Therefore, we retrospectively 
investigated the clinical characteristics of TB 
patients in our tertiary hospital. 
MATERIALS AND METHODS  
   The subjects consisted of 80 patients who 
Mycobacterium tuberculosis (MTB) was isolated 
from clinical specimens and who received a definite 
diagnosis of TB in Kawasaki Medical School 
Hospital between January 2010 and June 2018. 
We retrospectively investigated the backgrounds, 
laboratory findings including interferon-γ 
release assays (IGRAs), microbiological findings, 
radiological findings, length from the first visit 
to diagnosis of TB, and outcomes of these TB 
patients. The timing of TB diagnosis was judged 
by the culturing or polymerase chain reaction 
(PCR)-based identification of MTB from clinical 
specimens. Regarding the judgment of IGRAs 
(QFT or T-SPOT), we followed the guidelines 
proposed by the Centers for Disease Control 
and prevention (CDC) for QFT５） and the UK 
guidelines for T-SPOT to diagnose TB published 
by NCCCC６）. Because there are no isolation rooms 
for tuberculosis patients in our tertiary hospital, we 
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respiratory diseases: 80%) and 12 (15%) received 
immunosuppressive treatment. The detection 
methods consisted of clinical symptoms such as 
fever and productive cough (75%) in most patients 
and periodical examination or follow-up period for 
other underlying diseases (25%). Seventy-three 
patients (91%) were admitted to our hospital for a 
final diagnosis, and the remaining 7 patients were 
diagnosed with TB in the outpatient department. 
Although most patients could be diagnosed within 
one month (73/80; 91%), the remaining seven 
patients required over one month to receive a 
diagnosis of TB and there was an inpatient with 
HIV infection and myelodysplastic syndrome and 
another inpatient with lower lung field tuberculosis 
who required three months after admission for TB 
diagnosis in this study. The rate of diagnosis on 
admission was the same between TB and non-TB 
disease (50 vs. 50%, respectively). In the patients 
with non-TB disease, pneumonia was the most 
frequent and, secondly, pulmonary non-TB disease 
was diagnosed in several patients (Table 2). It was 
Table 1. Backgrounds of tuberculosis patients in our tertiary hospital
Backgrounds Number of patients (n=80)
Age (Mean± S.D.) 68.3±19.0
Sex (Male：Female) 43:37
Smoking history (+) 47 (59%)
Alcohol abuse (+) 6 (8%)
Underlying disease (+) (with repetition) 68 (85%)
　　Respiratory disease 21 (26%)
　　　　　　　CDPD 9
　　　　　　　Old pulmonary tuberculosis 5
　　　　　　　Others 7
　　Non-respiratory disease 64 (80%)
　　　　　　　Malignant disease 12
　　　　　　　Gastrointestinal disease 11
　　　　　　　Cerebral vascular disease 10
　　　　　　　Diabetes mellitus 10
　　　　　　　Collagen disease 10
　　　　　　　Renal disease (including CRD) 5
　　　　　　　HIV infection 2
　　　　　　　Others 4
　　Immunosuppressive treatment 12 (15%)
Previous treatment for tuberculosis (+) 6 (8%)
COPD: Chronic obstructive pulmonary disease, HIV: Human immunodeficiency virus
Table 2. Diagnosis on admission or initial consultation with tuberculosis patients (n=80)
Diagnosis Number of patients (n=80）
Tuberculosis 40 (50%)




Non-tuberculous disease 40 (50%)
　　Pneumonia 15 (19%)
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difficult to make a final diagnosis in these patients. 
   Concerning the results of IGRAs, QFT showed 
a positive response in 60 of the 80 patients (75%), 
but was negative in 16 and indeterminate in 4. On 
the other hand, T-SPOT showed a positive response 
in 64 of 79 patients (81%), but was negative in 
13 and indeterminate in 2. Among the laboratory 
findings, while hypoalbuminemia (albumin ≦3.5 g/
dL) related to the general conditions was recognized 
in 53/80 (66%) TB patients, lymphocytopenia 
(lymphocyte count ≦1000) related to the immune 
status was recognized in 35/80 (44%) TB patients. 
   Regarding the radiological findings, pulmonary 
lesions including miliary TB showed the following: 
(1) the lesion existed in both lungs in 39 of 66 
patients (59%), the right lung in 21, and left lung in 
6, (2) a cavity lesion was not frequently recognized 
in 16 of 66 patients (25%), (3) the lesion existed 
within one-third of the unilateral lung field in 28 of 
66 patients (42%), within the unilateral lung field 
in 25 (38%), and exceeded the unilateral lung field 
in 13 (20%) (Table 3). Miliary TB was recognized 
in 10 of 66 patients (15%) (Fig. 1). So-called lower 
lung field pulmonary TB (8) was recognized in 5 of 
Table 3. Radiological findings of tuberculosis patients (66 patients with pulmonary lesion)



































Pleural effusion 5 (8%)
Lower lung field dominant 5 (8%)
＊: Radiological classification according to the Japanese Society for Tuberculosis 
‡:  1; within half of unilateral lung field, 2; within unilateral lung field, 3; exceeding 
unilateral lung field
a b
Fig. 1. A 43-year-old woman showed diffuse small nodular shadows in the bilateral lung field on a chest 
radiograph (a) and diffuse small nodular shadows in the bilateral lung on chest CT (b). (Diagnosis: Miliary 
tuberculosis)
45Kobashi Y, et al. : Clinical characteristics of tuberculosis patients
66 patients (8%) (Fig. 2).
   The  methods  to  d iagnose  TB invo lved 
expectorated sputum in 26 patients, bronchoscopic 
specimens in 32, lung biopsy tissue in 17, and other 
clinical specimens in 5. Both smear and culture 
tests of clinical specimens were positive in 61 of 
the 80 patients (76%) and the remaining patients 
were negative for smear tests but culture tests were 
positive. However, there was one patient with an 
isoniazid (INH)-resistant strain and three patients 
with a streptomycin (SM)-resistant strain based on a 
drug sensitivity test (Table 4).
   The final diagnose of the 80 patients consisted 
of 56 patients with pulmonary TB and 36 patients 
with extrapulmonary TB (tuberculous lymphangitis 
11, miliary tuberculosis 10, tuberculous pleurisy 6, 
Fig. 2. A 83-year-old man showed an infiltrative shadow in the right lower lung field on a chest radiograph (a) 
and a similar shadow in the right lower lobe with emphysematous change on chest CT (b). (Diagnosis: Lower 
lung field tuberculosis) 
a b
Table 4: Diagnostic methods for tuberculosis patients (n=80)










Others (Pus, Cerebral spinal fluid, Pleural effusion, etc)  5 (6%)
　　Smear-positive, culture-positive 3
　　Smear-negative, culture-positive 2
Multidrug-resistant (INH ≧0.2 μg/mL, RFP ≧40 μg/mL) 0
INH-resistant (INH ≧0.2 μg/mL) 1
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spinal tuberculosis 3, tuberculous meningitis 2, and 
others 4) (Table 5).
   Concerning the outcome of 80 TB patients, 59 
patients were transferred to another hospital with 
isolation rooms for TB patients after diagnosis 
immediately and the remaining 21 patients started 
antituberculous therapy in our hospital. Although 
antituberculous therapy were performed for most 
TB patients except for 2 patients who died before 
treatment, the precise clinical course or state of 
treatment continuation was unknown for most TB 
patients transferred to another hospital. Finally, 
nine patients died due to severe TB or worsening 
of underlying diseases before the completion of 
antituberculous treatment.
DISCUSSION
   We retrospectively analyzed the clinical findings 
of TB patients in our tertiary hospital without 
isolation rooms for TB patients through this 
study. Subsequently, we revealed the following 
clinical characteristics: 1) Most TB patients had 
underlying diseases, malignant diseases were 
frequently recognized, and TB patients who 
received immunosuppressive treatment developed 
miliary TB; 2) Diagnoses on admission led to the 
same frequency of non-TB disease and TB, and 
pneumonia was the most frequent non-TB disease; 
3) TB patients tend to show poorer nutritional 
conditions such as hypoalbuminemia, and the results 
of IGRAs (QFT or T-SPOT) showed negative or 
indeterminate responses compared with previous 
reports５，６）; 4) Pulmonary lesions including miliary 
TB showed atypical shadows without a cavity in 
many TB patients; 5) The diagnostic method to 
obtain a definite diagnosis most frequently involved 
bronchoscopic specimens. 
   Concerning risk factors of TB pathogenesis, 
malignancy, collagen vascular disease, HIV 
infection, and diabetes mellitus were described in 
previous reports８－10）. In patients with malignancy, 
both immunosuppression due to malignancy itself 
and the influence of anticancer therapy have been 
reported to reactivate M. tuberculosis during 
dormancy into an old TB lesion and evoke active 
TB. The complication rate of pulmonary TB during 
the follow-up of lung cancer was reported to be high 
(2~10%)11，12） and a similar finding was recognized 
in this study. On the other hand, immunosuppressive 
drugs such as corticosteroid or biological drugs were 
recently administered to many patients with collagen 
vascular disease. These drugs also decreased 
immunity against TB infection and evoked active 
TB (1.7~4-fold increase in risk within six months 
after the initiation of treatment) 13－15）. Therefore, the 
Japanese College of Rheumatology or the Japanese 
Society for Tuberculosis stated that a preventive 
Table 5. Final diagnosis of tuberculosis patients (n=80)




Pulmonary tuberculosis + Tuberculous pleurisy 5
Spinal tuberculosis 3
pulmonary tuberculosis + Tuberculous meningitis 2
Pulmonary tuberculosis + Tuberculous lymphadenitis 2
Tuberculous pleurisy 1
Bronchial tuberculosis 1
Pulmonary tuberculosis + Bronchial tuberculosis 1
Cerebral tuberculosis + Tuberculous lymphadenitis 1
Pulmonary tuberculosis + Tuberculous peritonitis 1
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antituberculous drug (isoniazid 300  mg/day 
administration for six or nine months) was necessary 
for these patients when immunosuppressive 
drugs were administered16，17）. Centers for Disease 
control and Prevention (CDC) also recommended 
preventive antituberculous therapy for nine months 
and reported the clinical effectiveness for HIV- 
positive patients18）. Because there were no patients 
receiving preventive antituberculous therapy among 
12 patients with immunosuppressive treatment in 
this study, we consider the importance of preventive 
antituberculous therapy to reduce severe TB 
such as miliary TB. Although there were few TB 
patients with HIV infection in our tertiary hospital, 
the number of patients with HIV infection has 
recently increased in Japan. If these patients show a 
decrease of CD4 lymphocytes due to HIV infection, 
they easily develop active, severe TB including 
extrapulmonary TB19）. Because they show atypical 
radiological findings without a cavity, we always 
have to be careful regarding the appearance of TB 
in these patients. 
   In spite of the retrospective nature of this 
study, we positively investigated the results of 
IGRAs (QFT or T-SPOT) for most TB patients. 
Subsequently, QFT showed a positive response 
in 75% and T-SPOT showed a positive response 
in 81%. These results are lower than in previous 
reports (>90%)５，６）. Komiya et al. also previously 
reported that the positive response rate of QFT 
was low in immunocompromised patients because 
of the decrease in lymphocyte counts or poorer 
nutritional conditions20）. Because there were many 
TB patients with an immunocompromised state due 
to underlying diseases in this study, we think that 
the severity of underlying diseases influenced the 
results of IGRAs. Therefore, although IGRAs may 
be useful to support a diagnosis of TB disease, we 
have to be careful regarding the definite diagnosis 
of TB disease in tertiary hospitals.
   Regarding the radiological findings related to 
pulmonary TB, miliary (Fig. 1) and lower lung field 
(Fig. 2) TB were frequently recognized in 10 (13%) 
and 5 (6%) patients, respectively. Typical findings 
such as a cavity showed a low rate (25%). Because 
TB patients in the tertiary hospital showed various 
atypical radiological findings, it was necessary to 
conduct acid-fast bacilli examinations using many 
clinical specimens. 
   We found that non-TB disease showed the 
same frequency as TB based on the diagnosis on 
admission or initial consultation in this study. 
Because there were eight patients (10%) who 
required over one month to receive the correct 
diagnosis, it was considered important to make a 
correct diagnosis by bronchoscopy. Fortunately, 
there were no TB patients with multi-drug resistant 
M. tuberculosis in our hospital in this study. 
Therefore, if we send patients to special hospitals 
with isolation rooms for TB patients as soon 
as possible, we can protect against nosocomial 
infection and initiate earlier antituberculous 
treatment.
   There are a few limitations of our study. First, it 
was a retrospective study that used medical records 
for data collection. Secondly, we studied a small 
number of TB patients (80 patients) because our 
hospital is a tertiary hospital without isolation 
rooms for TB patients. Thirdly, we could not 
obtain complete data on the content of treatment or 
prognosis due to the transfer of patients to special 
hospitals with isolation rooms for TB patients after 
a definite diagnosis in most cases.
   In conclusion, TB patients in our tertiary hospital 
had many underlying diseases such as malignant 
or autoimmune diseases and were receiving 
immunosuppressive treatment. Therefore, because 
IGRAs showed a lower positive response rate than 
previous data and radiological findings also did 
not show typical findings, it is important to apply 
diagnostic methods positively such as bronchoscopy 
as soon as possible. 
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